Tatva Chintan Pharma Chem (BOM:543321) Total Liabilities : ₹816 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Tatva Chintan Pharma Chem Total Liabilities?

Tatva Chintan Pharma Chem's Total Liabilities for the quarter that ended in Mar. 2024 was ₹816 Mil.

Tatva Chintan Pharma Chem's quarterly Total Liabilities declined from Sep. 2023 (₹1,128.79 Mil) to Dec. 2023 (₹0.00 Mil) but then increased from Dec. 2023 (₹0.00 Mil) to Mar. 2024 (₹816.36 Mil).

Tatva Chintan Pharma Chem's annual Total Liabilities increased from Mar. 2022 (₹1,849.66 Mil) to Mar. 2023 (₹2,415.09 Mil) but then declined from Mar. 2023 (₹2,415.09 Mil) to Mar. 2024 (₹816.36 Mil).

Tatva Chintan Pharma Chem Total Liabilities Historical Data

The historical data trend for Tatva Chintan Pharma Chem's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tatva Chintan Pharma Chem Total Liabilities Chart

Tatva Chintan Pharma Chem Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

1,312.44

1,488.39

1,849.66

2,415.09

816.36

Tatva Chintan Pharma Chem Quarterly Data
	Mar19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial												2,415.09	-	1,128.79	-	816.36

Tatva Chintan Pharma Chem Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Tatva Chintan Pharma Chem's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	796.63	+	(6.39	+	13.34
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	816

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	8187.18	-	7370.82
	=	816

Tatva Chintan Pharma Chem's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	796.63	+	(6.39	+	13.34
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	816

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	8187.18	-	7370.82
	=	816

Tatva Chintan Pharma Chem Total Liabilities Related Terms

Thank you for viewing the detailed overview of Tatva Chintan Pharma Chem's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Tatva Chintan Pharma Chem (BOM:543321) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Tatva Chintan Pharma Chem Ltd (BOM:543321) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

TATVA:India

Address

Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010

Website

https://www.tatvachintan.com

Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.

Tatva Chintan Pharma Chem (BOM:543321) Headlines

No Headlines